These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 3896154

  • 1. [Phase II studies of interferon alpha-2 Sch 30500 in advanced gastrointestinal carcinoma].
    Furue H.
    Gan To Kagaku Ryoho; 1985 Aug; 12(8):1625-9. PubMed ID: 3896154
    [Abstract] [Full Text] [Related]

  • 2. [Recombinant interferon alpha-2 (Sch 30500) in patients with head and neck cancer].
    Miyake H, Horiuchi M, Togawa K, Kawamoto K, Kaneko T, Inuyama Y, Honda Y, Baba S, Matsunaga T, Ishikawa T.
    Gan To Kagaku Ryoho; 1985 Aug; 12(8):1651-5. PubMed ID: 3896156
    [Abstract] [Full Text] [Related]

  • 3. [Clinical study of recombinant interferon alpha-2 (Sch 30500) in advanced gynecological cancers].
    Kasamatsu T, Ohmi K, Takeuchi S, Takamizawa H, Matsuzawa M, Kawana T, Ueda K, Kubo H, Tsumuji Y, Kawashima Y.
    Gan To Kagaku Ryoho; 1985 Aug; 12(8):1656-60. PubMed ID: 3896157
    [Abstract] [Full Text] [Related]

  • 4. [Phase I study of human lymphoblastoid alpha-interferon on malignant tumor].
    Furue H.
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):977-83. PubMed ID: 3963861
    [Abstract] [Full Text] [Related]

  • 5. [Phase II study of recombinant leukocyte A interferon (Ro 22-8181) in hematological malignancies].
    Gan To Kagaku Ryoho; 1985 Apr; 12(4):928-35. PubMed ID: 3885864
    [Abstract] [Full Text] [Related]

  • 6. Phase II trial of lymphoblastoid interferon in metastatic colon carcinoma.
    Chaplinski T, Laszlo J, Moore J, Silverman P.
    Cancer Treat Rep; 1983 Nov; 67(11):1009-12. PubMed ID: 6640552
    [Abstract] [Full Text] [Related]

  • 7. Immunomodulation by recombinant interferon-alpha 2 in a phase I trial in patients with lymphoproliferative malignancies.
    Ozer H, Gavigan M, O'Malley J, Thompson D, Dadey B, Nussbaum-Blumenson A, Snider C, Rudnick S, Ferraresi R, Norred S.
    J Biol Response Mod; 1983 Nov; 2(6):499-515. PubMed ID: 6607323
    [Abstract] [Full Text] [Related]

  • 8. [Phase II study of recombinant human leukocyte A interferon on urogenital cancer patients].
    Yoshimoto J, Tsushima T, Matsumura Y, Ohmori H, Saito N, Tanaka H, Asahi T, Ohkita K, Tanahashi T, Nanba K.
    Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):465-70. PubMed ID: 4004282
    [Abstract] [Full Text] [Related]

  • 9. [Phase II study of recombinant leukocyte A interferon (Ro 22-8181) in skin malignant tumors].
    Gan To Kagaku Ryoho; 1985 Apr; 12(4):936-42. PubMed ID: 2985007
    [Abstract] [Full Text] [Related]

  • 10. [A cooperative phase I-II study of HLBI in patients with malignant tumors].
    Kimura K.
    Gan To Kagaku Ryoho; 1984 Jun; 11(6):1324-31. PubMed ID: 6329104
    [Abstract] [Full Text] [Related]

  • 11. Phase I study of Wellferon (human lymphoblastoid alpha-interferon) as cancer therapy: clinical results.
    Sarna G, Figlin R, McCarthy S.
    J Biol Response Mod; 1983 Jun; 2(2):187-95. PubMed ID: 6644335
    [Abstract] [Full Text] [Related]

  • 12. Treatment of renal cell carcinoma with alpha (human leukocyte) interferon and vinblastine in combination: a phase I-II trial.
    Figlin RA, deKernion JB, Maldazys J, Sarna G.
    Cancer Treat Rep; 1985 Mar; 69(3):263-7. PubMed ID: 3978656
    [Abstract] [Full Text] [Related]

  • 13. Phase I study of human leukocyte interferon in patients with advanced cancer.
    Horning SJ, Levine JF, Meyer M, Merigan TC, Rosenberg SA.
    J Biol Response Mod; 1983 Mar; 2(1):47-56. PubMed ID: 6196450
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Phase I study of a recombinant gamma interferon (S-6810)].
    Ogawa M, Takaku F, Maekawa T, Ota K, Ichimaru M, Izuo M, Takakura K, Ikeda S, Koiso K, Machida T.
    Gan To Kagaku Ryoho; 1987 Feb; 14(2):446-52. PubMed ID: 3101608
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
    Colón-Otero G, Marschke R, Camoriano JK, Sorensen JM, Sloan JA, Richardson RL.
    Cancer J Sci Am; 1997 Feb; 3(5):297-302. PubMed ID: 9327154
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.